{"id":80312,"date":"2025-12-29T19:35:11","date_gmt":"2025-12-29T14:05:11","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=80312"},"modified":"2025-12-29T19:35:11","modified_gmt":"2025-12-29T14:05:11","slug":"bulk-drug-park","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/bulk-drug-park\/","title":{"rendered":"Bulk Drug Park, Development, Features, Structure, Impact"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Bulk Drug Park is a strategic industrial initiative of the Government of India aimed at strengthening domestic manufacturing of bulk drugs, also known as Active Pharmaceutical Ingredients. India has a globally strong pharmaceutical sector, yet it remains dependent on imports for several critical bulk drugs due to cost advantages abroad. To address this vulnerability, the Department of Pharmaceuticals launched the Bulk Drug Park Scheme in 2020 with a total outlay of Rs. 3000 crore. The initiative focuses on creating large scale, integrated manufacturing ecosystems with shared infrastructure to reduce production costs, enhance quality compliance, and improve supply security for essential medicines.<\/span><\/p>\n<h2><b>Bulk Drug Park<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk Drug Parks in India are dedicated manufacturing zones created to support large scale production of APIs, drug intermediates, and key starting materials. Under the national scheme, three states: Himachal Pradesh, Gujarat, and Andhra Pradesh received in principle approval after competitive evaluation of proposals submitted by thirteen states. These parks are spread across large contiguous land parcels and are designed to provide world class common infrastructure facilities. The scheme reflects cooperative federalism, where the Centre provides financial assistance while states execute and operate the parks through dedicated implementing agencies.<\/span><\/p>\n<h2><b>Bulk Drug Park Development<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk Drug Park development focuses on cost reduction, infrastructure sharing, and scale efficiency to strengthen India\u2019s domestic API manufacturing ecosystem.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Central Financial Support: The scheme provides up to Rs. 1000 crore per park to develop common infrastructure, reducing capital burden on individual manufacturers.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Scheme Outlay: A total budget of Rs. 3000 crore was approved in 2020 exclusively for three Bulk Drug Parks nationwide.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">State Participation: 13 states submitted proposals, but only 3 were selected through quantitative and qualitative assessment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Advisory Oversight: Proposal appraisal was guided by an Advisory Committee chaired by the CEO of <a href=\"https:\/\/vajiramandravi.com\/upsc-exam\/niti-aayog\/\" target=\"_blank\"><strong>NITI Aayog<\/strong><\/a>.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Differential Funding: Gujarat and Andhra Pradesh receive 70% central assistance, while Himachal Pradesh receives 90% due to hilly terrain.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Implementation Timeline: States were instructed to submit Detailed Project Reports within 90 days of in principle approval.<\/span><\/li>\n<\/ul>\n<h2><b>What are Bulk Drugs<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk drugs are chemically or biologically active substances that provide therapeutic value to medicines and form the core of pharmaceutical formulations.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Active Role: Bulk drugs, also called Active Pharmaceutical Ingredients (APIs), are responsible for the intended pharmacological effect of medicines.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Manufacturing Stage: APIs are produced before formulation into tablets, capsules, syrups, or injections.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Economic Importance: Bulk drugs account for a major share of pharmaceutical manufacturing cost structures.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Trade Value: India exported bulk drugs and intermediates worth Rs. 33,320 crore in 2021 &#8211; 22.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Import Dependence: Despite strong exports, bulk drugs constituted over 60% of pharmaceutical imports due to pricing factors.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Examples: Paracetamol, ibuprofen, cephalosporins, steroids, and proton pump inhibitors are commonly used APIs.<\/span><\/li>\n<\/ul>\n<h2><b>Bulk Drug Park Structure<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk Drug Park structure is based on large contiguous land areas supported by centralized infrastructure and state level implementing agencies.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Land Requirement: Each park must have at least 1000 acres, while hilly states require a minimum of 700 acres.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">State Implementing Agency: A legally registered agency manages day to day operations and infrastructure maintenance.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Central Oversight: The Department of Pharmaceuticals monitors progress and compliance through a Project Management Agency.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Industrial Zoning: Land is demarcated for manufacturing units, utilities, logistics, and environmental infrastructure.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Single Site Proposal: Each state is permitted to propose only one park location under the scheme.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Infrastructure Focus: Financial assistance is strictly limited to common infrastructure facilities, not individual units.<\/span><\/li>\n<\/ul>\n<h2><b>Bulk Drug Park Impact<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk Drug Parks are expected to transform India\u2019s API manufacturing capacity by reducing imports, improving resilience, and increasing exports.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Import Reduction: Domestic API capacity expansion reduces reliance on foreign suppliers for essential drug components.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cost Efficiency: Shared infrastructure lowers manufacturing costs, improving price competitiveness globally.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Employment Creation: Parks generate large scale direct and indirect employment in pharmaceutical manufacturing and services.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Export Growth: Improved scale and quality strengthen India\u2019s position as a global API supplier.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Supply Security: Localized production ensures uninterrupted supply during global disruptions and emergencies.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Industrial Clustering: Concentration of manufacturers enhances collaboration, innovation, and process optimization.<\/span><\/li>\n<\/ul>\n<h2><b>Bulk Drug Park Significance<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk Drug Parks play a crucial role in strengthening pharmaceutical self reliance, healthcare affordability, and industrial competitiveness.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Self Reliance: Parks support national goals of reducing strategic dependence on imported APIs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Healthcare Access: Lower API costs help maintain affordability of essential medicines for consumers.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Industry Competitiveness: Domestic manufacturers gain cost and compliance advantages in global markets.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Quality Assurance: Central testing and standardized utilities improve product reliability and safety.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Crisis Preparedness: Enhanced domestic capacity enables rapid scale up during pandemics or supply shocks.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Federal Cooperation: Joint Centre State participation reflects cooperative <a href=\"https:\/\/vajiramandravi.com\/upsc-exam\/federalism-in-indian-polity\/\" target=\"_blank\"><strong>federalism<\/strong><\/a> in industrial policy.<\/span><\/li>\n<\/ul>\n<h2><b>Bulk Drug Park Challenges<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Bulk Drug Parks face challenges related to execution timelines, environmental management, and long term commercial viability.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">High Initial Costs: Infrastructure heavy development requires sustained funding and timely disbursement.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Environmental Compliance: Managing chemical waste and effluents demands advanced technology and strict oversight.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Market Competition: Domestic APIs must compete with lower cost imports from established global suppliers.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Execution Delays: Land acquisition and infrastructure development may face administrative bottlenecks.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Skill Availability: Specialized chemical manufacturing requires skilled technical manpower at scale.<\/span><\/li>\n<\/ul>\n<h3><b>Way forward<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">To address the issues, reform strategies focus on timely execution, technological upgrading, and integration with broader pharmaceutical incentives.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Fast Track Approvals: Streamlined clearances can reduce project delays and cost overruns.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PLI Integration: Linking parks with API focused PLI schemes improves commercial viability.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Skill Development: Targeted training programs can address workforce requirements.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Technology Adoption: Advanced waste treatment and green chemistry reduce environmental risks.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Market Support: Export facilitation and procurement assurance encourage manufacturer participation.<\/span><\/li>\n<\/ul>\n<h2><b>Bulk Drug Park Examples<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Approved Bulk Drug Parks demonstrate large scale planning and regional diversification across India.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Himachal Pradesh Park: Spread across 1402.44 acres at Haroli, Una district, with 90% central funding support.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gujarat Park: Located at Jambusar, Bharuch district, covering 2015.02 acres with 70% assistance.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Andhra Pradesh Park: Developed across 2000.45 acres at K.P. Puram and Kodhada in East Godavari district.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">First Mover Advantage: Gujarat\u2019s Jambusar park is considered India\u2019s first bulk drug park initiative.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Investment Potential: Parks are expected to attract thousands of crores in private pharmaceutical investment.<\/span><\/li>\n<\/ul>\n<h2><b>Bulk Drug Park Recent Developments<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Recent developments highlight political oversight, investment potential, and on ground progress of Bulk Drug Parks.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">High Level Committee: A monitoring committee chaired by the Union Chemicals and Fertilizers Minister oversees progress.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Foundation Stone: The Prime Minister laid the foundation stone for the Una park in October 2022.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Investment Estimate: The Himachal Pradesh park alone is expected to attract around Rs. 10,000 crore investment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Employment Impact: The Una park is projected to generate employment for over 20,000 people.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PLI Synergy: Fourteen API projects under the PLI scheme have already commenced production, complementing park objectives.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Long Term Vision: Bulk Drug Parks are positioned as foundational infrastructure for India\u2019s pharmaceutical future.<\/span><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Bulk Drug Park is a Government of India initiative to strengthen domestic API production, cut imports, lower costs and ensure medicine supply security.<\/p>\n","protected":false},"author":25,"featured_media":80238,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[786],"tags":[4488],"class_list":{"0":"post-80312","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-general-studies","8":"tag-bulk-drug-park","9":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/80312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=80312"}],"version-history":[{"count":0,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/80312\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/80238"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=80312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=80312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=80312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}